Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Propranolol demonstrates antifungal activity against Fusarium and Apergillus corneal isolates and in a murine model of fungal keratitis.
Author Affiliations & Notes
  • Michael E Zegans
    Dartmouth Health, Lebanon, New Hampshire, United States
    Dartmouth College, Hanover, New Hampshire, United States
  • Kevin K Fuller
    The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
  • Cecilia Gutierrez-Perez
    Dartmouth College, Hanover, New Hampshire, United States
  • Chetan Pavuluri
    Dartmouth Health, Lebanon, New Hampshire, United States
    Weill Cornell Medicine, New York, New York, United States
  • Ruina Bao
    Dartmouth College, Hanover, New Hampshire, United States
  • Brandon Ross
    Dartmouth College, Hanover, New Hampshire, United States
  • Galini Poimenidou
    Dartmouth College, Hanover, New Hampshire, United States
  • N Venkatesh Prajna
    Aravind Eye Hospital, Madurai, Tamil Nadu, India
  • K Dharmalingam
    Aravind Eye Hospital, Madurai, Tamil Nadu, India
  • Robert Cramer
    Dartmouth College, Hanover, New Hampshire, United States
  • Footnotes
    Commercial Relationships   Michael Zegans None; Kevin Fuller None; Cecilia Gutierrez-Perez None; Chetan Pavuluri None; Ruina Bao None; Brandon Ross None; Galini Poimenidou None; N Venkatesh Prajna None; K Dharmalingam None; Robert Cramer None
  • Footnotes
    Support  NEI R21 EY02877-01
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1963. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Michael E Zegans, Kevin K Fuller, Cecilia Gutierrez-Perez, Chetan Pavuluri, Ruina Bao, Brandon Ross, Galini Poimenidou, N Venkatesh Prajna, K Dharmalingam, Robert Cramer; Propranolol demonstrates antifungal activity against Fusarium and Apergillus corneal isolates and in a murine model of fungal keratitis.. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1963.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Fungal keratitis (FK) is an infection of the cornea that frequently results in the need for corneal transplantation even with prompt topical ocular antifungal therapy. Natamycin remains the only FDA-approved drug for FK, but prompt sterilization of the cornea is often not attained. Recently, natamycin synergy with the beta-adrenergic antagonist timolol against Fusarium species was reported. In this study we characterize the in vitro antifungal effects of additional beta-adrenergic antagonists against FK-relevant molds and explore their effects in a murine model of FK.

Methods : Microbroth dilution assays were used to determine the minimal inhibitory concentration (MIC) of beta-adrenergic antagonists against 18 Fusarium spp. isolates (10 from the Mycotic Ulcer Treatment Trial, 8 from USA) and 3 Aspergillus fumigatus isolates. The fractional inhibitory concentration index (FICI) was calculated to assess interactions with natamycin. A corneal abrasion model followed by inoculation was used to create fungal corneal infections in mice. C57BL/6J corneas were inoculated with A. fumigatus and treated with propranolol both topically (0.1% drops; 3X daily starting on day 0) and via intraperitoneal injection (2 mg/kg; 1x daily starting on day -1). Sham-treated animals received topical and i.p. PBS (n=10/group).

Results : Most beta-blockers did not show antifungal activity or synergy with natamycin with the exception of propranolol. A racemic mix of propranolol had fungicidal activity with MIC between 31 and 83 μg/mL for the Fusarium isolates. The MIC of the less cardioactive R enantiomer was lower (27-83 μg/mL) than the MIC of the S enantiomer (42-104 μg/mL). The MICs of both propranolol and natamycin were lower in combination but were not synergistic. The MIC of propranolol was 156 μg/mL for the A. fumigatus isolates. In a murine model of Aspergillus FK, viable fungus was not recovered in any of propranolol treated animals after at 72 hours post-inoculation and clinical grading was mild compared to saline treated controls

Conclusions : These data suggest that propranolol has antifungal activity against the two predominant FK pathogens, Fusarium and Aspergillus, and that it may have a role in the treatment of FK.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×